CALL US AT: (949) 396-0330
CONNECT WITH NEMUS BIOSCIENCE INC.:

NEMUS Bioscience, Inc.

NEMUS Bioscience Inc. is a biopharmaceutical company focused on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids.

SEC Filings

Date Filing Description Download
12-29-2016 8-K Current report filing
12-06-2016 424B3 Prospectus filed pursuant to Rule 424(b)(3)
12-05-2016 EFFECT Effectiveness Order
11-22-2016 S-1 Securities Registration Statement
11-09-2016 10-Q Quarterly Report
11-09-2016 424B3 Prospectus filed pursuant to Rule 424(b)(3)
11-03-2016 D Small Company Offering and Sale of Securities Without Registration
10-28-2016 424B3 Prospectus filed pursuant to Rule 424(b)(3)
10-27-2016 8-K Current report filing
10-26-2016 8-K Current report filing
08-15-2016 424B3 Prospectus filed pursuant to Rule 424(b)(3)
08-12-2016 10-Q Quarterly Report
08-12-2016 8-K Current report filing
07-13-2016 424B3 Prospectus filed pursuant to Rule 424(b)(3)
07-13-2016 8-K Current report filing
05-27-2016 DEF 14A Proxy Statement (definitive)
05-13-2016 424B3 Prospectus filed pursuant to Rule 424(b)(3)
05-13-2016 10-Q Quarterly Report
04-26-2016 424B3 Prospectus filed pursuant to Rule 424(b)(3)
04-25-2016 EFFECT Effectiveness Order
04-21-2016 CT ORDER Confidential Treatment Order
03-22-2016 POS AM Post-Effective Amendment to Registration Statement
03-21-2016 10-K Annual Report
03-01-2016 CT ORDER Confidential Treatment Order
02-11-2016 424B3 Prospectus filed pursuant to Rule 424(b)(3)
02-11-2016 8-K Current report filing
02-01-2016 SC 13D/A Amended Statement of Beneficial Ownership